|
Delayed
TEL AVIV STOCK EXCHANGE
13:55:33 20/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 1,435.00 ILa | +0.49% |
|
-6.51% | -11.31% |
| 09-08 | InterCure Regains Nasdaq Compliance | MT |
| 08-24 | InterCure Ltd. announced that it has received ILS 21.711643 million in funding from Bennu Pharma Fund Ltd and other investors. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Stocks
- INCR Stock
- Charts InterCure Ltd.
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
